A research article in the Two studies on the potential benefits of the GLP-1 receptor agonist tirzepatide were presented at the SCAI 2026 Scientific Sessions & CAIC-ACCI Summit in Montreal in April
As a step therapy medication Contrave is a common step therapy requirement before insurance plans will approve GLP-1 medications like Wegovy or Zepbound
In cases where lifestyle changes are insufficient, consulting with a healthcare professional for alternative laxatives or treatments is advisable
PMID: 31373028 14 Systemic primary carnitine deficiency induces severe arrhythmia due to shortening of QT interval
This approval marked a significant advancement in the therapeutic landscape for this vulnerable population
Excellent fibre sources include oats, chia seeds, flaxseeds, beans, lentils, apples, whole grains, vegetables, and nuts